NMD-VCell Neuromuscular Virtual Cell Research PlatformEvidence → perturbation → experiment → outcome
Publication addendum v08.7 · design sensitivity mapped · prospective execution bridge open · outcomes remain blinded

NAR publication addendum · curated v08.7

Two pairs define a bounded ADAM10 pilot—not general DMD validation.

A deterministic 480-scenario design-sensitivity grid quantifies what the prospective paired design can and cannot conclude before any candidate outcome is accessed.

Evidence-to-experiment bridge · v08.8 → v09.1

From design sensitivity to accountable execution.

The sensitivity analysis now feeds a linked lock, study-amendment, randomization and outcome-ingestion system. One shared evidence base routes 39 governed decisions into 56 independent assignments, 15 prospective checks and three checksum-bound reviewer packets—turning a design result into a portable, auditable handoff.

Formal lockINPUT PHASE39 authority decisions to define
v08.8 amendmentEXTERNAL STEPregistration follows review
RandomizationSEALEDreleased after registration
Outcome accessBLINDEDopened after the prospective freeze
Experimental unit

Independent model pair for generalization; differentiations are nested support. Wells, guides and cells never inflate n.

Sample-size gate

Two pairs remain Stage A calibration. Stage B pair count requires endpoint-specific variance and effect/margin approval.

Outcome return

Append-only contract retains positive, null, toxic, discordant, failed-QC and inconclusive results.

2 pairs · effect 1 SD9.3%concordant-call probability
6 pairs · effect 1 SD43.3%concordant-call probability
6 pairs · effect 2 SD80.5%concordant-call probability
Maximum null false concordance2.58%across all null scenarios

Supplementary Figure S32

Operating characteristics expose the cost of few independent backgrounds.

Three differentiations and three guides are within-pair support; they are not additional disease backgrounds. Reference assumptions: heterogeneity SD 0.25, guide retention 0.95, equivalence margin 0.50 SD and variance multiplier 4.

Open figure/source manifest →
Four-panel Figure S32 showing concordant-call probability by true effect and pair count, decision state probabilities, null false concordance and variance multiplier sensitivity.

One result, four synchronized surfaces

Website, manuscript, figure and attachments resolve to the same evidence object.

SurfacePrimary objectBoundary
ManuscriptSuccessor manuscript manifestAdditive over frozen v08.6
SupplementSupplement/addendum manifestFigure S32 and Tables S65–S66
FigureFigure/source manifestSame frozen probabilities
AttachmentsTables S65–S66 manifestChecksummed public packet

Version separation

This addendum does not silently relabel another release.

Scientific resourcev1.2.0-measured-dmd-evidence

Unchanged.

Publication addendumcurated v08.7

New design-sensitivity layer over frozen v08.6.

Other manuscript packetScience Advances v09.80

Retained separately and not replaced.

Fail-closed claim boundary

Simulation precision is not biological efficacy.

There are 0 observed DMD candidate response outcomes. Thirty-nine endpoint-, model-pair-, QC- and authority-specific fields remain unresolved. Non-significance is not equivalence; the current object authorizes neither wet-lab execution, public deposit nor submission.

Inspect blocked lock template manifest